Locations:
Search
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Screening assay effective across all stages, can identify tissue of origin
Leveraging the prognostic significance of sentinel lymph node biopsy histologic patterns
Study finds that even patients with extensive disease benefit from treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis
Some supplements associated with negative patient outcomes
Early screening, first-line therapy choice critical
Cleveland Clinic-led study lays groundwork for more personalized treatments
Luspatercept shows promise for patients with few options
Searching for new insights into drug resistance, collateral sensitivity
Advertisement
Advertisement